Share-based Payments (Tables)
|
12 Months Ended |
Jun. 30, 2022 |
|---|
| Disclosure Of Share Based Payment Arrangements Text Block Abstract |
|
| Schedule of options vested |
| Date granted |
|
Number of
options Vested |
|
Exercise price |
|
Vesting date |
|
Expiry date |
| N/A |
|
Nil |
|
Nil |
|
N/A |
|
N/A |
| Total |
|
Nil |
|
|
|
| Schedule of number of options outstanding over unissued ordinary shares |
| Grant Date |
|
Number of
options
exercised |
|
|
Exercise price A$ |
|
|
Vesting date |
|
Expiry date |
| 21 Dec 2016 |
|
|
750,000 |
|
|
$ |
0.10 |
|
|
31 Dec 2018 |
|
31 Dec 2021 |
| 21 Dec 2016 |
|
|
500,000 |
|
|
$ |
0.10 |
1 |
|
26 Oct 2019 |
|
30 Dec 2021 |
| 31 Jul 2018 |
|
|
250,000 |
|
|
$ |
0.50 |
1 |
|
31 Dec 2019 |
|
31 Dec 2022 |
| 31 Jul 2018 |
|
|
250,000 |
|
|
$ |
0.50 |
1 |
|
31 Dec 2020 |
|
31 Dec 2023 |
| 12 Feb 2019 |
|
|
58,333 |
|
|
$ |
0.60 |
|
|
5 Mar 2019 |
|
20 Feb 2022 |
| 27 Nov 2019 |
|
|
500,000 |
|
|
$ |
0.60 |
|
|
4 Dec 2020 |
|
4 Dec 2022 |
| 24 Feb 2020 |
|
|
100,000 |
|
|
$ |
0.50 |
2 |
|
31 Jan 2021 |
|
31 Jan 2022 |
| Total |
|
|
2,408,333 |
|
|
|
|
|
|
|
|
|
| Grant Date | |
Number of
options
granted | | |
Exercise price
A$ | | |
Vesting date | |
Expiry date |
| 1 Feb 2019 | |
| 200,000 | | |
$ | 0.65 | | |
31 Dec 2019 | |
31 Dec 2022 |
| 1 Feb 2019 | |
| 200,000 | | |
$ | 0.65 | | |
31 Dec 2020 | |
31 Dec 2023 |
| 27 Nov 2019 | |
| 1,000,000 | | |
$ | 0.60 | | |
4 Dec 2020 | |
4 Dec 2022 |
| 19 Oct 2020 | |
| 1,000,000 | | |
$ | 1.60 | | |
19 Oct 2020 | |
19 Oct 2023 |
| 7 Feb 2022 | |
| 140,000 | | |
$ | 1.10 | | |
7 Feb 2022 | |
18 Jan 2025 |
| 7 Feb 2022 | |
| 700,000 | | |
$ | 1.50 | | |
7 Feb 2022 | |
7 Feb 2025 |
| Total | |
| 3,240,000 | | |
| | | |
| |
|
|
| Schedule of options over unissued shares occurred |
| | |
2022 | | |
2022 | | |
2021 | | |
2021 | |
| | |
No. | | |
WAEP A$ | | |
No | | |
WAEP A$ | |
| Outstanding at 1 July | |
| 4,873,333 | | |
$ | 1.041 | | |
| 11,450,000 | | |
$ | 0.366 | |
| Granted during the year | |
| 840,000 | | |
$ | 1.433 | | |
| 1,000,000 | | |
$ | 1.200 | |
| Exercised during the year | |
| (2,408,333 | ) | |
$ | 0.316 | | |
| (7,476,667 | ) | |
$ | 0.471 | |
| Forfeited/cancelled during the year | |
| (65,000 | ) | |
$ | 0.600 | | |
| (100,000 | ) | |
$ | 0.500 | |
| Outstanding at 30 June | |
| 3,240,000 | | |
$ | 1.131 | | |
| 4,873,333 | | |
$ | 1.041 | |
| Exercisable at 30 June | |
| 3,240,000 | | |
$ | 1.131 | | |
| 4,873,333 | | |
$ | 1.041 | |
| | |
2022 | | |
2022 | | |
2021 | | |
2021 | |
| | |
No. | | |
WAEP A$ | | |
No | | |
WAEP A$ | |
| Outstanding at 1 July | |
| 4,873,333 | | |
$ | 1.041 | | |
| 11,450,000 | | |
$ | 0.366 | |
| Granted during the year | |
| 840,000 | | |
$ | 1.433 | | |
| 1,000,000 | | |
$ | 1.200 | |
| Exercised during the year | |
| (2,408,333 | ) | |
$ | 0.316 | | |
| (7,476,667 | ) | |
$ | 0.471 | |
| Forfeited/cancelled during the year | |
| (65,000 | ) | |
$ | 0.600 | | |
| (100,000 | ) | |
$ | 0.500 | |
| Outstanding at 30 June | |
| 3,240,000 | | |
$ | 1.131 | | |
| 4,873,333 | | |
$ | 1.041 | |
| Exercisable at 30 June | |
| 3,240,000 | | |
$ | 1.131 | | |
| 4,873,333 | | |
$ | 1.041 | |
|
| Schedule of options issued during the current reporting period were valued using the Black-Scholes option |
| Date granted |
|
Number of
options
granted |
|
|
Exercise
price
A$ |
|
|
Expiry date |
|
Risk free
interest rate
used |
|
|
Volatility
applied |
|
|
Value per
Option
A$ |
|
| 7 Feb 2022 |
|
|
700,000 |
|
|
$ |
1.50 |
|
|
7 Feb 2025 |
|
|
1.39 |
% |
|
|
95.8 |
% |
|
$ |
0.160 |
|
| 7 Feb 2022 |
|
|
140,000 |
|
|
$ |
1.10 |
|
|
18 Jan 2025 |
|
|
1.39 |
% |
|
|
95.8 |
% |
|
$ |
0.184 |
|
|
| Schedule of reporting period the following performance rights were granted |
| Grant Date | |
No of
Rights | | |
Expiry Date | |
Fair Value per
Right at Grant
Date | | |
Vesting |
| 6 Nov 2020 | |
| 50,000 | | |
6 Nov 2026 | |
A$ | 0.85 | | |
6 Nov 2021 |
| 11 Dec 2020 | |
| 10,000,000 | | |
16 Dec 2025 | |
A$ | 0.68-$0.93 | | |
Performance based with 5 milestones |
| Total | |
| 10,050,000 | | |
| |
| | | |
|
|
| Schedule of number of performance rights outstanding over unissued ordinary shares |
| Grant Date | |
No of
Rights | | |
Expiry Date | |
Fair Value per
Right at Grant
Date | | |
Vesting |
| 3 Mar 2017 | |
| 2,000,000 | | |
3 Mar 2022 | |
A$ | 0.72 | | |
Vested and exercised |
| 3 Sep 2018 | |
| 3,000,000 | | |
3 Sep 2021 | |
A$ | 0.185 | | |
Vested and exercised |
|
| Schedule of performance rights outstanding |
| Grant Date | |
No of
Rights | | |
Expiry Date | |
Fair Value per
Right at Grant
Date | | |
Vesting |
| 6 Nov 2020 | |
| 50,000 | | |
6 Nov 2026 | |
A$ | 0.85 | | |
Vested, not exercised |
| 11 Dec 2020 | |
| 2,000,000 | | |
16 Dec 2025 | |
A$ | 0.68 | | |
Vested, not exercised |
| 11 Dec 2020 | |
| 2,000,000 | | |
16 Dec 2025 | |
A$ | 0.79 | | |
Vested, not exercised |
| 11 Dec 2020 | |
| 2,000,000 | | |
16 Dec 2025 | |
A$ | 0.85 | | |
Vested, not exercised |
| 11 Dec 2020 | |
| 2,000,000 | | |
16 Dec 2025 | |
A$ | 0.90 | | |
Vested, not exercised |
| 11 Dec 2020 | |
| 2,000,000 | | |
16 Dec 2025 | |
A$ | 0.93 | | |
Vested, not exercised |
| Total | |
| 10,050,000 | | |
| |
| | | |
|
|
| Schedule of Performance rights with vesting criteria based on length of service were valued using the Company’s |
| Milestone | |
Number of
rights granted | | |
Share price
target | | |
Risk free
interest rate
used | | |
Volatility
applied | | |
Value per
Right (cents) | |
| 1 | |
| 2,000,000 | | |
A$ | 1.20 | | |
| 0.04 | % | |
| 125 | % | |
| 67.8 | |
| 2 | |
| 2,000,000 | | |
A$ | 1.30 | | |
| 0.09 | % | |
| 125 | % | |
| 78.7 | |
| 3 | |
| 2,000,000 | | |
A$ | 1.40 | | |
| 0.10 | % | |
| 125 | % | |
| 85.1 | |
| 4 | |
| 2,000,000 | | |
A$ | 1.50 | | |
| 0.22 | % | |
| 125 | % | |
| 90.5 | |
| 5 | |
| 2,000,000 | | |
A$ | 1.70 | | |
| 0.35 | % | |
| 125 | % | |
| 93.1 | |
|
| Schedule of share-based payment transactions |
| | |
A$ | |
| Shares issued for services rendered in relation to the NASDAQ listing | |
| 979,638 | |
| Shares issued to directors as remuneration | |
| 920,000 | |
| Performance rights issued to directors and employees as remuneration | |
| 6,394,571 | |
| Options issued to directors as remuneration | |
| 112,188 | |
| Options issued to advisers as remuneration | |
| 25,824 | |
| | |
| 8,432,221 | |
|